Specific macrophage RhoA targeting (SMART) CRISPR-Cas9 for mitigating osteoclastogenesis-induced joint damage in inflammatory arthritis

Published: 14 June 2024| Version 1 | DOI: 10.17632/y4d9rzrnr6.1
Contributor:
JINGQIN CHEN

Description

This is a raw data and supplemental information of the manuscript "Specific macrophage RhoA targeting (SMART) CRISPR-Cas9 for mitigating osteoclastogenesis-induced joint damage in inflammatory arthritis"

Files

Categories

Rheumatoid Arthritis

Licence